The Oncologist’s Garden: Outside the garden may seem as dead as a stone but inside, the seasonal Amaryllis’s are just showing off 😀

D. Ross Camidge I’ve been sharing those with my oncologists for the holidays every year Nice to watch flowers grow /..not cancer. 🫶🏽

Denver sunset as flame tree tonight

The Oncologist’s Garden: Surgical Oncology - pass me the chainsaw, nurse. For those with ennui or dips in their self-esteem, I can recommend nothing better than an axe and a chainsaw and some big tree branches to cytoreduce. Cheap, healthy and life-affirming

Seasons greetings for all for those into it or over it

ISJET paper now available on line as pdf. Fast turnaround by JTO. The Use of Investigator-Assigned Subjective or Judgmental Efficacy and Toxicity Reporting in Early Phase Clinical Trials of Lung Cancer Treatments - ScienceDirect sciencedirect.com/science/articl…

Always good to reflect at this time of year. One life, lived the best you can. To the best of all possible futures 🥸

With today’s news about ami/laz - we shouldnt forget its prothrombotic effects and that these dont go away if you use osi instead of Lazertinib. Today’s case series as evidence: Early onset thrombosis when combining Osimertinib and Amivantamab sciencedirect.com/science/articl…

Power together: 11 years ago the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC) began. Beyond designing and running trials the amount of patient level data that colleagues could share and learn from was amazing. Just like this- pubmed.ncbi.nlm.nih.gov/39758601/

For a full thread on how MET amp more resembles a PDL1 type predictive biomarker and a summary of our decade of research - check out Drcamidge bluesky account

In this episode of #OncLiveOnAir, Alec Watson, MD, of CU Anschutz highlights a retrospective analysis examining how oncogene overlap could identify clinically relevant thresholds for MET, KRAS, and HER2 gene copy number gain in NSCLC. #lcsm LISTEN: onclive.com/view/oncogene-…

Dr Decoster was the driving force behind collating data on targeted therapy in the elderly. As the same chronological age people are not in anyway the same biological age, it can only be a loose checklist but it’s still a first in the field. sciencedirect.com/science/articl…

In this episode of How This Is Building Me, D. Ross Camidge, MD, PhD, and Adrienne A. Boire, MD, PhD, discuss Dr Boire's path to becoming a physician-scientist. D. Ross Camidge Memorial Sloan Kettering Cancer Center #oncology #MedEd LISTEN: onclive.com/view/a-nuanced…

Tailored cancer vaccine combined with PD-1 blockade in phase 1 trial  @icr_london  D. Ross Camidge bit.ly/40CHemx

In the latest episode of How This is Building Me, D. Ross Camidge of CU Cancer Center and Rahul Gosain, MD, MBA of Wilmot Cancer Institute, discuss the importance of oncology generalists in meeting the high demand for medical oncologists. LISTEN: onclive.com/view/how-gener… #oncology #MedEd

In today’s episode of How This Is Building Me, Drs D. Ross Camidge and Tim Eisen, MB BChir, PhD, discuss Dr Eisen's dual career in academia and industry and how industry experience can enhance drug development. LISTEN: onclive.com/view/how-acade… #OncologyOnAir #oncology #MedEd

The Oncologist’s Garden: After the winter months of dormancy happy commensals are returning. Come follow more on Bluesky as I move away from here - not away from your company but away from the unasked for chaos that is thrust along without your permission on this platform

Feed cleanse. Trying to stay centered admiring the orchids growing in our garden (despite the toxic environment) D. Ross Camidge